TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Panel Meeting Canceled; New Senior Executive Service Draws Enthusiastic Response At NCI July 13, 1979
TCL Archive In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge June 25, 1982
TCL Archive DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million January 28, 1983
